Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Madsen

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Diagnostics (Basel, Switzerland)|June 21, 2016
Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction in MinipigsThomas Rasmussen, Bjarke Follin, Jens Kastrup, et al.
Bioconjugate Chemistry|December 6, 2017
Site-Specific <sup>64</sup>Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N<sub>3</sub>), Using Copper Free Click ChemistryTroels E Jeppesen, Lotte K Kristensen, Carsten H Nielsen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 6, 2010
A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humansDavid Erritzoe, Klaus Holst, Vibe G Frokjaer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 30, 2006
Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approachSteven Haugbøl, Lars H Pinborg, Haroon M Arfan, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Fully Automated GMP-Compliant Synthesis of [<sup>18</sup>F]FE-PE2IKlas Bratteby, Charlotte Lund Denholt, Szabolcs Lehel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 16, 2016
Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?Hans Rasmussen, Vibe G Frokjaer, Rikke W Hilker, et al.
Psychoneuroendocrinology|April 2, 2010
Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor bindingVibe G Frokjaer, David Erritzoe, Anders Juul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 11, 2011
11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurementsAnders Ettrup, Jens D Mikkelsen, Szabolcs Lehel, et al.
BMC Cancer|April 4, 2013
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in miceMette Munk Jensen, Kamille Dumong Erichsen, Camilla Bardram Johnbeck, et al.
Molecular Imaging and Biology|January 12, 2013
Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36Anders Ettrup, Søren Holm, Martin Hansen, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Diagnostics (Basel, Switzerland)|June 21, 2016
Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction in MinipigsThomas Rasmussen, Bjarke Follin, Jens Kastrup, et al.
Bioconjugate Chemistry|December 6, 2017
Site-Specific <sup>64</sup>Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N<sub>3</sub>), Using Copper Free Click ChemistryTroels E Jeppesen, Lotte K Kristensen, Carsten H Nielsen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 6, 2010
A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humansDavid Erritzoe, Klaus Holst, Vibe G Frokjaer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 30, 2006
Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approachSteven Haugbøl, Lars H Pinborg, Haroon M Arfan, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Fully Automated GMP-Compliant Synthesis of [<sup>18</sup>F]FE-PE2IKlas Bratteby, Charlotte Lund Denholt, Szabolcs Lehel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 16, 2016
Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?Hans Rasmussen, Vibe G Frokjaer, Rikke W Hilker, et al.
Psychoneuroendocrinology|April 2, 2010
Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor bindingVibe G Frokjaer, David Erritzoe, Anders Juul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 11, 2011
11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurementsAnders Ettrup, Jens D Mikkelsen, Szabolcs Lehel, et al.
BMC Cancer|April 4, 2013
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in miceMette Munk Jensen, Kamille Dumong Erichsen, Camilla Bardram Johnbeck, et al.
Molecular Imaging and Biology|January 12, 2013
Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36Anders Ettrup, Søren Holm, Martin Hansen, et al.
Pageof 11